Literature DB >> 9706218

Carnitine metabolism and its regulation in microorganisms and mammals.

C J Rebouche1, H Seim.   

Abstract

In procaryotes, L-carnitine may be used as both a carbon and nitrogen source for aerobic growth, or the carbon chain may be used selectively following cleavage trimethylamine. Under anaerobic conditions and in the absence of preferred substrates, some bacteria use carnitine, via crotonobetaine, as an electron acceptor. Formation of trimethylamine and lambda-butyrobetaine (from reduction of crotonobetaine) from L-carnitine by enteric bacteria has been demonstrated in rats and humans. Carnitine is not degraded by enzymes of eukaryotic origin. In higher organisms, carnitine has specific functions in intermediary metabolism. Concentrations of carnitine and its esters in cells of eukaryotes are rigorously maintained to provide optimal function. Carnitine homeostasis in mammals is preserved by a modest rate of endogenous synthesis, absorption from dietary sources, efficient reabsorption, and mechanisms present in most tissues that establish and maintain substantial concentration gradients between intracellular and extracellular carnitine pools.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706218     DOI: 10.1146/annurev.nutr.18.1.39

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  67 in total

1.  Absorbing competition for carnitine.

Authors:  P M Taylor
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

2.  Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.

Authors:  H H Huidekoper; J Schneider; T Westphal; F M Vaz; M Duran; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2006-08-02       Impact factor: 4.982

Review 3.  Pharmacological agents for NASH.

Authors:  Vlad Ratziu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-15       Impact factor: 46.802

Review 4.  Carnitine biosynthesis in mammals.

Authors:  Frédéric M Vaz; Ronald J A Wanders
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 5.  The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications.

Authors:  Jason R Goldsmith; R Balfour Sartor
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

6.  l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.

Authors:  Robert A Koeth; Betzabe Rachel Lam-Galvez; Jennifer Kirsop; Zeneng Wang; Bruce S Levison; Xiaodong Gu; Matthew F Copeland; David Bartlett; David B Cody; Hong J Dai; Miranda K Culley; Xinmin S Li; Xiaoming Fu; Yuping Wu; Lin Li; Joseph A DiDonato; W H Wilson Tang; Jose Carlos Garcia-Garcia; Stanley L Hazen
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

7.  L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation.

Authors:  G Fortin; K Yurchenko; C Collette; M Rubio; A-C Villani; A Bitton; M Sarfati; D Franchimont
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

8.  Carnitine worsens both injury and recovery of contractile function after transient ischemia in perfused rat heart.

Authors:  R Díaz; J Lorita; M Soley; I Ramírez
Journal:  J Physiol Biochem       Date:  2008-03       Impact factor: 4.158

9.  A mixture of the aqueous extract of Garcinia cambogia, soy peptide and L: -carnitine reduces the accumulation of visceral fat mass in rats rendered obese by a high fat diet.

Authors:  Yun Jung Kim; Keun-Young Kim; Min Sun Kim; Jin Hee Lee; Kang Pyo Lee; Taesun Park
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

10.  Characterization of Pseudomonas aeruginosa growth on O-acylcarnitines and identification of a short-chain acylcarnitine hydrolase.

Authors:  Jamie A Meadows; Matthew J Wargo
Journal:  Appl Environ Microbiol       Date:  2013-03-22       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.